Suppr超能文献

先天性免疫系统在全关节置换术中磨损碎屑诱导的炎性种植体周围骨溶解中的作用

The Role of the Innate Immune System in Wear Debris-Induced Inflammatory Peri-Implant Osteolysis in Total Joint Arthroplasty.

作者信息

Connors John Patrick, Stelzer John W, Garvin Patrick M, Wellington Ian J, Solovyova Olga

机构信息

Department of Orthopaedic Surgery, University of Connecticut, Farmington, CT 06032, USA.

出版信息

Bioengineering (Basel). 2022 Dec 4;9(12):764. doi: 10.3390/bioengineering9120764.

Abstract

Periprosthetic osteolysis remains a leading complication of total hip and knee arthroplasty, often resulting in aseptic loosening of the implant and necessitating revision surgery. Wear-induced particulate debris is the main cause initiating this destructive process. The purpose of this article is to review recent advances in understanding of how wear debris causes osteolysis, and emergent strategies for the avoidance and treatment of this disease. A strong activator of the peri-implant innate immune this debris-induced inflammatory cascade is dictated by macrophage secretion of TNF-α, IL-1, IL-6, and IL-8, and PGE2, leading to peri-implant bone resorption through activation of osteoclasts and inhibition of osteoblasts through several mechanisms, including the RANK/RANKL/OPG pathway. Therapeutic agents against proinflammatory mediators, such as those targeting tumor necrosis factor (TNF), osteoclasts, and sclerostin, have shown promise in reducing peri-implant osteolysis in vitro and in vivo; however, radiographic changes and clinical diagnosis often lag considerably behind the initiation of osteolysis, making timely treatment difficult. Considerable efforts are underway to develop such diagnostic tools, therapies, and identify novel targets for therapeutic intervention.

摘要

假体周围骨溶解仍然是全髋关节和膝关节置换术的主要并发症,常常导致植入物无菌性松动并需要翻修手术。磨损产生的颗粒碎片是引发这一破坏过程的主要原因。本文旨在综述在理解磨损碎片如何导致骨溶解方面的最新进展,以及预防和治疗该疾病的新策略。这种由碎片引发的炎症级联反应是植入物周围固有免疫的强力激活剂,由巨噬细胞分泌的肿瘤坏死因子-α、白细胞介素-1、白细胞介素-6、白细胞介素-8和前列腺素E2所主导,通过激活破骨细胞并通过包括RANK/RANKL/OPG途径在内的多种机制抑制成骨细胞,导致植入物周围骨吸收。针对促炎介质的治疗药物,如那些靶向肿瘤坏死因子(TNF)、破骨细胞和硬化蛋白的药物,已在体外和体内减少植入物周围骨溶解方面显示出前景;然而,影像学改变和临床诊断往往在骨溶解开始后相当长一段时间才出现,使得及时治疗变得困难。目前正在大力开发此类诊断工具和疗法,并确定治疗干预的新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ab4/9774505/24d42e24bf34/bioengineering-09-00764-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验